期刊文献+

Potential of molecular chaperones for treating Alzheimer’s disease

下载PDF
导出
摘要 Alzheimer’s disease(AD)is the most prevalent form of dementia,i.e.,progressive memory loss and profound cognitive dysfunction,resulting in a considerable societal burden.At the neuropathological level,the brains of AD patients exhibit amyloid-β(Aβ)plaques,neurofibrillary tangles,and neuroinflammation(Sala Frigerio and De Strooper,2016).
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2024年第11期2343-2344,共2页 中国神经再生研究(英文版)
基金 supported by grants from the Alzheimer’s Association Research Grant(to GC) Olle Engkvists Stiftelse(to GC) the Petrus and Augusta Hedlunds Stiftelse(to GC) Ake Wibergs stiftelse(to GC) the Swedish Alzheimer foundation(to GC) the Ahlén Stiftelsens(to GC) Karolinska Institutet Research Foundation Grant(to GC) the Stiftelsen for Gamla Tjanarinnor(to GC) the Stiftelsen Sigurd och Elsa Goljes Minne(to GC) the Loo and Hans Osterman Foundation(to GC) Geriatric Diseases Foundation at Karolinska Institutet(to GC) the Gun and Bertil Stohne’s Foundation(to GC) the Magnus Bergvall Foundation(to GC).
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部